Authors


Samuel S. Chuang, PhD

Latest:

Outsourcing of Nonclinical Studies for Drug Development: Tips and Trends

Learning to think with the end in mind will help clients and their selected CRO to design and conduct the right studies.


Kevin Vermeulen

Latest:

Supplier-Change Management for Drug-Product Manufacturers

An effective supplier-initiated change management process is discussed.



Kevin McLaughlin

Latest:

Logistics of Cleaning Validation

A guide for improving the planning and preparation of future validation work.



Jessica de Rooij

Latest:

Novel Hydrophobic Interaction Chromatography Resins for Next Generation Biotherapeutic Challenges

Designed to solve complex downstream separation and purification challenges for many biotherapeutic modalities, a suite of hydrophobic chromatography resins (POROS HIC) has been developed that cover a wide range of hydrophobicity.


Orjana Terova

Latest:

Novel Hydrophobic Interaction Chromatography Resins for Next Generation Biotherapeutic Challenges

Designed to solve complex downstream separation and purification challenges for many biotherapeutic modalities, a suite of hydrophobic chromatography resins (POROS HIC) has been developed that cover a wide range of hydrophobicity.


John Li

Latest:

Novel Hydrophobic Interaction Chromatography Resins for Next Generation Biotherapeutic Challenges

Designed to solve complex downstream separation and purification challenges for many biotherapeutic modalities, a suite of hydrophobic chromatography resins (POROS HIC) has been developed that cover a wide range of hydrophobicity.


Rathin C. Das, PhD

Latest:

Angiopoietins: Novel Targets for Anti-angiogenesis Therapy

The authors review the angiopoietin pathway as an alternative for safer and more efficacious anti-angiogenic therapeutics.


Gary Dailey

Latest:

Applying Lessons Learned from the Semiconductor Industry

Applying lessons of raw materials’ characterization and supply-chain control from the semiconductor industry allow more rigorous control of the biopharmaceutical manufacturing process.


Claudia Berron

Latest:

Applying Lessons Learned from the Semiconductor Industry

Applying lessons of raw materials’ characterization and supply-chain control from the semiconductor industry allow more rigorous control of the biopharmaceutical manufacturing process.


Cristina Peixoto

Latest:

Using TEM-Based Image Analysis to Validate the Presence of HA Spikes on Influenza VLPs

The authors of this study demonstrate an innovative method that is useful and complements traditional HA assays.


Sofia B. Carvalho

Latest:

Using TEM-Based Image Analysis to Validate the Presence of HA Spikes on Influenza VLPs

The authors of this study demonstrate an innovative method that is useful and complements traditional HA assays.


Martin Ryner

Latest:

Using TEM-Based Image Analysis to Validate the Presence of HA Spikes on Influenza VLPs

The authors of this study demonstrate an innovative method that is useful and complements traditional HA assays.


Nina Forsberg

Latest:

Using TEM-Based Image Analysis to Validate the Presence of HA Spikes on Influenza VLPs

The authors of this study demonstrate an innovative method that is useful and complements traditional HA assays.


Vanessa Carvalho

Latest:

Using TEM-Based Image Analysis to Validate the Presence of HA Spikes on Influenza VLPs

The authors of this study demonstrate an innovative method that is useful and complements traditional HA assays.


Feliza Mirasol

Latest:

INTERPHEX 2024: Single-Use Technologies Reinforce Fluid-Handling Workflows

BioPharm International® sat down with Nicole Hunter, Watson-Marlow Fluid Technology Solutions’ head of Global WMArchitect at INTERPHEX 2024, to discuss the impact of single-use technologies on fluid-handling workflows in bioprocessing.


Johan Zebib

Latest:

Review by Exception: Connecting the Dots for Faster Batch Release

In batch production, efficient exception management means reducing the time required to identify, review, and resolve process exceptions. Incorporating review by exception functionality within manufacturing execution system (MES) software can streamline biopharmaceutical product release.


Chelsea Pratt, PhD

Latest:

Challenging Microbial Sanitization of a Liquid Chromatography System

To ensure that no contaminating or hazardous residual components remain after protein purification during biologic development, additional sanitization steps may be required for the instrumentation utilized during these processes.


Shreekant Karmarkar

Latest:

Building Strategic Relationships with CROs

How to adopt win-win strategies and understand quality agreements for complying with cGMP when building strategic relationships with pharmaceutical contract research organizations.


Dominic Clarke

Latest:

The Evolving Role of Starting Materials in Cell and Gene Therapy

Accelerated approval pathways and growing demand for cell and gene therapies are putting pressure on providers of cellular starting materials, and they must ensure a steady supply.


Brad Taylor

Latest:

The Evolving Role of Starting Materials in Cell and Gene Therapy

Accelerated approval pathways and growing demand for cell and gene therapies are putting pressure on providers of cellular starting materials, and they must ensure a steady supply.


Margaret Marino

Latest:

Antibody Purification Process Development and Manufacturing

Downstream process development and manufacturing play a crucial role to ensure safety, quality, identity, purity, and efficacy.


Naheed Sayeed

Latest:

Lessons from FDA 483s and cGMP Inspection Data

Production and process controls, organization and personnel were the top problems found, while packaging and labeling citations increased in 2017 and 2018.


Marzena Ingram

Latest:

Assessing Manufacturing Process Robustness

A structured assessment process can determine compliance to lifecycle process-validation requirements for biopharmaceuticals.


Sio2 Medical

Latest:

Revolutionary Sample Preservation for DNA/RNA Analysis

The Synergy Tube is a BCT specifically designed to optimize nucleic acid recovery and cancer tumor cells (CTC) from the point of blood draw. The Synergy Tube and proprietary stabilizer dramatically improve the quantity and quality of these components for downstream genetic diagnostics.


Christopher Weikart

Latest:

Revolutionary Sample Preservation for DNA/RNA Analysis

The Synergy Tube is a BCT specifically designed to optimize nucleic acid recovery and cancer tumor cells (CTC) from the point of blood draw. The Synergy Tube and proprietary stabilizer dramatically improve the quantity and quality of these components for downstream genetic diagnostics.


A. Poles Lahille

Latest:

Comparing Fed-Batch Cell Culture Performances of Stainless Steel and Disposable Bioreactors

A case study to compare the performances of several types of mixing in disposable bags with stainless steel bioreactors.


Satabdi Rautray

Latest:

Therapeutic Potential of Green, Synthesized Gold Nanoparticles

This study aims to use plant-leaf extract for the green synthesis of gold nanoparticles and to evaluate their antibacterial and antioxidant activity.


A. Usha Rajananthini

Latest:

Therapeutic Potential of Green, Synthesized Gold Nanoparticles

This study aims to use plant-leaf extract for the green synthesis of gold nanoparticles and to evaluate their antibacterial and antioxidant activity.

© 2025 MJH Life Sciences

All rights reserved.